Opens in a new tab

Edwards Lifesciences v Meril (CFI, 10 January 2025)

Date10 January 2025
CourtCFI
DivisionMunich (DE) Local Division
Type of actionInfringement Action
Case number(s)UPC_CFI_249/2023
Registry referenceApp_3187/2024 · ORD_4627/2024 · UPC_CFI_249/2023
PartiesEdwards Lifesciences Corporation v. Meril GmbH, Meril Life Sciences Pvt Ltd.

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 10 January 2025 (UPC_CFI_249/2023, ORD_4627/2024), the judge-rapporteur of the Munich Local Division fixed at EUR 244,000 the costs that Meril GmbH and Meril Life Sciences must reimburse to Edwards Lifesciences following provisional measures proceedings, an amount the parties had agreed, but refused to add interest. Neither the UPCA nor the Rules of Procedure provide for interest on costs fixed in cost assessment proceedings, and Rules 125 and 131 cannot be applied by analogy. The point matters to any party awaiting reimbursement: time spent in cost assessment is not compensated.

Question

Do costs fixed in cost assessment proceedings under Rules 150 and 151 carry interest?

Decision

No. Only the claim to interest at five points above the base rate under § 247 BGB was disputed. Rules 125 and 131, which concern damages and expressly provide for interest (Rule 131.2(a)), cannot be extended as there is no unintended gap. Rule 151 contains no comparable requirement. A party successful in provisional measures proceedings may in any event seek interim reimbursement of costs, enforceable immediately (Rules 221.1(d) and 242.2(a)). Whether lost interest may be recovered as damages is left open. Meril must pay EUR 244,000 within 20 days, the remainder of the application is dismissed.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 68(2) and 82
Rules of Procedure
Rules 125, 131, 150, 151, 156.2, 157, 221 and 242.2
Case law cited
Meril Life Sciences v Edwards Lifesciences, Court of Appeal, 18 January 2024 (relied on by the applicant)

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Patent infringement action.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_249/2023 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 14 August 2023 Edwards Lifesciences v Meril (CFI, 14 August 2023) Application for provisional measures · UPC_CFI_249/2023

    La signification par le CMS à la première défenderesse vaut signification alternative à la seconde, réputée intervenue le 7 août 2023.

  2. 28 August 2023 Edwards Lifesciences v Meril (CFI, 28 August 2023) Application for provisional measures · UPC_CFI_249/2023

    Une audience sur la demande de mesures provisoires est fixée au 10 octobre 2023, avec interprétation simultanée pour la formation, et les délais de réponse à l'opposition sont arrêtés.

  3. 19 December 2023 Meril v Edwards Lifesciences (CFI, 19 December 2023) Application for provisional measures · UPC_CFI_249/2023

    La procédure de mesures provisoires est éteinte par l'engagement de cessation des défenderesses, qui supportent l'intégralité des frais dans la limite de 200 000 euros. L'appel est autorisé.

  4. 10 January 2025 Edwards Lifesciences v Meril (CFI, 10 January 2025) Infringement Action · UPC_CFI_249/2023

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
Le juge rapporteur condamne Meril à rembourser 244 000 euros de frais à Edwards Lifesciences dans les 20 jours et rejette la demande d’intérêts, faute de base légale.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.